Analysis of the twelve cases of immune-related myocarditis caused by cadonilimab
The clinical use of cadonilimab is complex, necessitating individualized monitoring for immune-related myocarditis based on the patient's condition. Furthermore, patient education is essential to ensure medication safety.
Authors
- Zijing Zhao (ORCID: https://orcid.org/0000-0001-8618-7002)
- Pisin Chen (ORCID: https://orcid.org/0000-0001-5251-7210)
- Haiying Zheng (ORCID: https://orcid.org/0000-0001-9050-5309)
- J. Li (ORCID: https://orcid.org/0000-0003-4819-4978)
Institutions
- Central South University (CN)
- Hunan Cancer Hospital (CN)
- Gansu Provincial Maternal and Child Health Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-17
- DOI
- https://doi.org/10.3389/fonc.2025.1671973
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05